TENAX THERAPEUTICS, INC. TENX Cash Flow

Tenax therapeutics, inc. (TENX)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Oct'15	Sep'15	Jul'15	Jun'15	Mar'15	Jan'15	Oct'14	Jul'14	Jan'14	Oct'13	Jul'13	Jan'13	Oct'12	Jul'12	Apr'12	Jan'12	Oct'11	Jul'11	Jan'11	Oct'10	Jul'10
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss
0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-15,429	-13,007	-	-13,546	0	-13,913	0	0	0	0	-	-	-	-	-15,057	-16,429	-15,712	0	0	0	0	0	0
Net Loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization
5	5	5	5	7	9	10	11	12	13	15	16	18	18	7	14	35	66	-	110	0	138	0	0	0	0	0	0	0	151	161	152	206	0	0	0	0	0	0
Amortization of right of use asset
104	102	75	50	24	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on disposal of property and equipment
0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of deferred compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0
Interest on debt instruments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	-	-	0	0	0	0	0	0	4,375	8,894	8,886	7,397	0	0	0	0	0	0
Loss on debt settlement and extinguishment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0
Loss on impairment, disposal and write down of long-lived assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	39	132	123	123	0	0	0	0	0	0
Issuance and vesting of compensatory stock options and warrants
183	171	203	254	305	316	327	364	407	498	590	572	560	529	946	889	348	293	-	262	0	273	0	0	0	0	0	0	0	85	66	33	65	0	0	0	0	0	0
Issuance of common stock below market value
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0
Issuance of common stock as compensation
-	-	-	-	-	190	136	263	138	79	79	80	80	1	25	25	1	1	-	1	0	50	0	0	0	0	0	0	0	190	222	177	127	0	0	0	0	0	0
Issuance of common stock for services rendered
125	100	91	0	0	100	75	100	100	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0
Issuance of note payable for services rendered
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0
Contributions of capital through services rendered by stockholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0
Change in the fair value of warrants
-	-	-	-	-	-	-	-	-	192	274	298	238	298	190	199	279	184	-	345	0	378	0	0	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-
Amortization of premium on marketable securities
-0	-1	7	11	43	91	111	153	167	187	245	338	502	652	717	836	887	860	-	890	0	681	0	0	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities
Accounts receivable, prepaid expenses and other assets
499	322	141	212	-8	122	136	-996	-986	-1,110	-1,164	-22	-62	-23	361	251	-58	-0	-	-350	0	599	0	0	0	0	0	0	0	265	294	-384	-74	0	0	0	0	0	0
Inventory
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	4	-18	-64	-7	0	0	0	0	0	0
Accounts payable and accrued liabilities
1,525	883	570	343	745	729	-166	-1,467	-4,695	-4,997	-3,944	-2,796	-965	1,895	144	-307	2,106	475	-	180	0	2,386	0	0	0	0	0	0	0	157	-1,133	-332	-404	0	0	0	0	0	0
Long term portion of lease liability
-105	-99	-74	-48	-23	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in operating activities
-8,094	-7,556	-7,027	-6,800	-6,073	-5,499	-5,583	-5,254	-9,661	-12,140	-13,963	-17,018	-16,588	-15,871	-16,469	-15,323	-12,270	-11,493	-	-11,016	0	-10,233	0	0	0	0	0	0	0	-4,901	-6,436	-7,837	-8,278	0	0	0	0	0	0
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of marketable securities
694	618	930	769	564	493	0	0	0	299	299	299	4,355	7,255	150	3,849	8,753	13,404	-	23,659	0	53,765	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Sale of marketable securities
-694	-620	-2,261	-3,076	-4,971	-7,856	-7,172	-6,930	-5,630	-4,053	-15,308	-17,551	-24,638	-29,390	-13,271	-13,599	-16,479	-19,891	-	-25,445	0	-15,052	0	0	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-
Purchase of property and equipment
0	3	5	5	8	7	5	7	4	4	4	3	3	2	7	23	19	16	-	16	0	0	0	0	0	0	0	0	0	21	21	30	17	0	0	0	0	0	0
Proceeds from the sale of property and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	4	4	4	0	0	0	-	-	-
Capitalization of patent costs and license rights
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15	-	35	0	84	0	0	0	0	0	0	0	142	153	182	247	0	0	0	0	0	0
Net cash provided by investing activities
0	-1	1,325	2,301	4,399	7,354	7,167	6,923	5,626	3,749	15,005	17,324	20,354	22,206	13,182	9,719	7,706	6,454	-	1,734	0	-38,797	0	0	0	0	0	0	0	-159	-170	-208	-261	0	0	0	0	0	0
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds for issuance of common stock and pre-funded warrants, net of issuance costs
0	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	0	0	-	0	-	-	0	0	0	0	0	0	114	8,114	8,733	8,733	0	0	0	0	0	0
Proceeds from the exercise of warrants
0	96	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repurchase of outstanding warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0
Proceeds from stockholder notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0
Proceeds from issuance of notes payable, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	102	137	137	837	0	0	0	0	0	0
Proceeds from convertible notes, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	4,514	0	0	0	0	0	0
Proceeds for issuance of convertible preferred stock, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-
Payments on notes - short-term
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	147	-	197	0	466	0	0	0	0	0	0	0	108	137	132	118	0	0	0	0	0	0
Payments on notes - long-term
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	8,000	8,000	8,000	0	0	0	-	-	-
Net cash provided by financing activities
2,130	96	9,003	9,003	9,003	8,907	0	0	0	-	-	-	-	-	-	-	-	-147	-	-197	0	77	0	0	0	0	0	0	0	2,608	6,114	6,739	9,467	0	0	0	0	0	0
Net change in cash and cash equivalents
-5,963	-7,461	3,301	4,504	7,328	10,762	1,583	1,669	-4,035	-8,391	1,041	305	3,765	6,335	-3,085	-5,450	-4,663	-5,185	-	-9,479	0	-48,952	0	0	0	0	0	0	0	-2,452	-492	-1,307	927	0	0	0	0	0	0
Interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	-	5	0	3	0	0	0	0	0	0	0	2	3	14	14	0	0	0	0	0	0
Income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0
Restricted stock issued during period in payment of interest on convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-
Common stock issued for payment of dividends on Series C Convertible Preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-
Restricted stock issued during period in payment of interest on convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-